Literature DB >> 33128353

A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.

Zhe Zhang1, Wen-Bin Hou2, Chao Zhang1, Yu-En Tan1, Dong-Dong Zhang1, Wen An1, Si-Wei Pan1, Wan-di Wu3, Qing-Chuan Chen1, Hui-Mian Xu1.   

Abstract

Six-Transmembrane Epithelial Antigene of the Prostate 1 (STEAP1) is associated with the occurrence and development of cancer. This study aimed to clarify the role of STEAP1 in gastric cancer tumour growth and metastasis, as well as its molecular mechanism of action.Statistical methods were used for clinical data analysis. Protein expression was detected using immunohistochemistry(IHC). The mRNA and protein expression in the cell cultures were detected using reverse transcription-polymerase chain reaction(RT-PCR) and western blot analysis. Overexpression and silencing models were constructed using plasmid and lentivirus transfection. To detect cell proliferation in vitro, Cell Counting Kit-8(CCK-8), flow cytometry and colony formation assays were used; transwell and wound healing assays were used to detect cell migration and invasion;For in vivo experiments, nude BALB/c mice were used for detecting subcutaneous tumorigenesis and intraperitoneal implantation. In the results,we found STEAP1 was overexpressed in gastric cancer tissues and cell lines. Single-factor and Cox analyses showed that STEAP1 gene expression level correlated with poor prognosis. Up-regulation of STEAP1 increased cell proliferation, migration and invasion, which decreased after STEAP1 was knocked down. These changes were achieved via the activation of the AKT/FoxO1 pathway and epithelial-mesenchymal transformation (EMT). The in vivo animal experiments showed that STEAP1 knock down, resulted in a decrease in the subcutaneous tumour and peritoneal tumour formation.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  STEAP1; gastric cancer; invasion; migration; proliferation

Mesh:

Substances:

Year:  2020        PMID: 33128353      PMCID: PMC7754049          DOI: 10.1111/jcmm.16038

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  35 in total

1.  Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.

Authors:  G Deep; R P Singh; C Agarwal; D J Kroll; R Agarwal
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

2.  Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p.

Authors:  Y Yang; N Xun; J-G Wu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-08       Impact factor: 3.507

3.  STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors.

Authors:  R S Hubert; I Vivanco; E Chen; S Rastegar; K Leong; S C Mitchell; R Madraswala; Y Zhou; J Kuo; A B Raitano; A Jakobovits; D C Saffran; D E Afar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  High expression of a Lewis(x)-related epitope in gastric carcinomas indicates metastatic potential and poor prognosis.

Authors:  B Mayer; I Funke; J P Johnson
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

5.  Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.

Authors:  Pia M Challita-Eid; Kendall Morrison; Soudabeh Etessami; Zili An; Karen J Morrison; Juan J Perez-Villar; Arthur B Raitano; Xiao-Chi Jia; Jean M Gudas; Steven B Kanner; Aya Jakobovits
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

Review 6.  Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix.

Authors:  Roberto Buccione; Giusi Caldieri; Inmaculada Ayala
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

7.  Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.

Authors:  Irene Y Cheung; Yi Feng; Karen Danis; Neerav Shukla; Paul Meyers; Marc Ladanyi; Nai-Kong V Cheung
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

8.  Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.

Authors:  Hiroya Kobayashi; Toshihiro Nagato; Keisuke Sato; Naoko Aoki; Shoji Kimura; Masamoto Murakami; Hajime Iizuka; Makoto Azumi; Hidehiro Kakizaki; Masatoshi Tateno; Esteban Celis
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

9.  Apoptosis index correlates with chemotherapy efficacy and predicts the survival of patients with gastric cancer.

Authors:  Yongning Jia; Bin Dong; Lei Tang; Yiqiang Liu; Hong Du; Peng Yuan; Aiwen Wu; Jiafu Ji
Journal:  Tumour Biol       Date:  2012-03-01

10.  Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.

Authors:  Bin Hou; Wenhan Li; Jianhui Li; Jia Ma; Peng Xia; Zhao Liu; Qingnuo Zeng; Xin Zhang; Dongmin Chang
Journal:  Oncol Rep       Date:  2019-12-20       Impact factor: 3.906

View more
  7 in total

Review 1.  The FOXO family of transcription factors: key molecular players in gastric cancer.

Authors:  Ying Liu; Xiang Ao; Yi Jia; Xiaoge Li; Yu Wang; Jianxun Wang
Journal:  J Mol Med (Berl)       Date:  2022-06-10       Impact factor: 5.606

2.  CORRIGENDUM.

Authors: 
Journal:  J Cell Mol Med       Date:  2022-01       Impact factor: 5.310

3.  DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines.

Authors:  Maria Urbanova; Verona Buocikova; Lenka Trnkova; Sabina Strapcova; Viera Horvathova Kajabova; Emma Barreto Melian; Maria Novisedlakova; Miroslav Tomas; Peter Dubovan; Julie Earl; Jozef Bizik; Eliska Svastova; Sona Ciernikova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

4.  The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.

Authors:  Chen Zhao; Kewei Xiong; Zhiqiang Ji; Fengming Liu; Xiangpan Li
Journal:  Oxid Med Cell Longev       Date:  2022-03-11       Impact factor: 6.543

5.  Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing's Sarcoma.

Authors:  Fatu Badiane Markey; Brigette Romero; Vijay Parashar; Mona Batish
Journal:  Cells       Date:  2021-05-24       Impact factor: 7.666

6.  A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.

Authors:  Zhe Zhang; Wen-Bin Hou; Chao Zhang; Yu-En Tan; Dong-Dong Zhang; Wen An; Si-Wei Pan; Wan-di Wu; Qing-Chuan Chen; Hui-Mian Xu
Journal:  J Cell Mol Med       Date:  2020-10-30       Impact factor: 5.295

Review 7.  Targeting iron metabolism in cancer therapy.

Authors:  Michael Morales; Xiang Xue
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.